Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
News

Oxford Genetics boosts cell/gene therapy R&D with new facility

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …
News

Wickham Laboratories Announces Renewal of FDA Accreditation

October 17, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now …
News
Press release

Apitope reclaims multiple sclerosis treatment from Merck after 7 years

October 17, 2016 Sales and Marketing ATX-MS-1467, Apitope, Merck, multiple sclerosis

Apitope has announced it has reclaimed the global rights to its multiple sclerosis (MS) treatment ATX-MS-1467 from Merck for the …
News

Valeant Pharmaceutical release their latest price increases

October 17, 2016 Sales and Marketing

Valeant Pharmaceutical announced, on 14 October, that their Patient Access and Pricing Committee had decided on a price range increase …
News

Hanmi Pharmaceutical raided over insider trading suspicions

October 17, 2016 Sales and Marketing Boehringer Ingelheim, Genentech, Hanmi Pharmaceutical, south korea

At the end of September, we reported on a busy 24-hour for Hanmi Pharmaceutical, as they secured a deal with …
News

EMA grants conditional approval for biliary cholangitis treatment

October 17, 2016 Sales and Marketing EMA, intercept, ocaliva, primary biliary cholangitis

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has voiced its approval of Intercept’s Ocaliva …
News

Celgene trial displays promising results for Crohn’s disease alternative treatment

October 17, 2016 Sales and Marketing Celgene, Celgene corporation, Crohn’s disease, clinical trials, crohn's disease, phase I, trial

Celgene International, part of Celgene Corporation, has released the results from a Phase Ib trial showing improvement in patients suffering …
News

Kite Pharma appoints Chris Nowers as Head of Europe

October 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Nowers, London, kite pharma

Kite Pharma announced on 13 October that it had appointed Chris Nowers as its Head of Europe. Nowers will be …
Appointment

NICE plans new “fast-track” appraisal option

October 14, 2016 Medical Communications, Sales and Marketing NHS, NICE

The National Institute for Health and Care Excellence (NICE) has proposed the introduction of a fast-track process which could make …
News

Pfizer loses UK patent infringement case over $5.1bn drug

October 13, 2016 Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, patent infringement, pregabalin

Pfizer has been dealt a significant blow as the UK Court of Appeal has rejected the company’s patent infringement claims …
News

Nordic Nanovector announces the appointment of Joanna Horobin as Non-Executive Board Director

October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nordic Nanovector, appointment, norway

Nordic Nanovector announced on 12 October that Joanna Horobin was elected to its Board as non-executive director at the company’s …
Appointment

Merck KgaA foresees meeting 2018 objectives and plans for 2022

October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, 2022, Germany, Merck KGaA

Speaking at its 2016 Capital Market Day about the progress it had made towards its 2018 objectives, CEO Stefan Oschmann …
News

Sanofi lowers Q3 sales figures from 2015

October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cipro, Plavix, Sanofi, financial results

Sanofi lowered its aggregate sales figure for Q3 2016 from €9.59 billion to €9.46 billion ahead of the release of …
News

New treatment for leukaemia nullifies cancer cells

October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boston, Cancer, Germany, Harvard, Mainz University, leukaemia

New research was able to demonstrate that a targeted drug-based inactivation of two chromatin regulators would interrupt the self-renewal of …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026